Skip to content Search the desk⌘ Ctrl K Agent Sign in O Orchestra BioMed Holdings, Inc.
O OBIO Orchestra BioMed Holdings, Inc.
O OBIO Orchestra BioMed Holdings, Inc.
Earnings When Orchestra BioMed Holdings, Inc. reports, what it reported each quarter, and how the stock took the results.
24 quarters. Sep 30, 2020 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 6 filings.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Mar 8 – Apr 2 Quarter by quarter 3 years 5 years 10 years
Revenue Net income EPS Operating income Operating cash flow Free cash flow
Q3 2026 $ 9 1 . 0 0 K $91.00K −89.4% vs Q3 2025
Q3 2026 Nov 10, 2026, after the close
Revenue $91.00K −89.4%
Net income -$18.75M N/M
EPS -$0.30 N/M Q2 2026 Aug 10, 2026, after the close
Orchestra BioMed Holdings, Inc. · CIK 1814114 · Engraved from SEC EDGAR
Revenue
$88.00K
−89.5% Q1 2026 May 12, 2026, after the close0.2% by the close of May 13
Revenue $110.00K −87.3%
Net income -$20.69M N/M
EPS -$0.33 N/M Q4 2025 Mar 12, 2026, before the open4.8% by the close of Mar 12
Revenue $30.92M +12,120.2%
Net income $6.25M N/M
EPS — —
Results day Typical move ±6.0% A typical move of 6.0% either way
Up after 6 of 12, down after 6.
−1.6% +41.3% −0.8%
When it reports
10-Q filed 41 to 43 days over its last 8
10-K filed 69 to 90 days over its last 6 ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d ended Dec 31, 2024 · filed Mar 31, 2025 · 90 d ended Mar 31, 2025 · filed May 12, 2025 · 42 d ended Jun 30, 2025 · filed Aug 12, 2025 · 43 d ended Sep 30, 2025 · filed Nov 10, 2025 · 41 d ended Dec 31, 2025 · filed Mar 12, 2026 · 71 d ended Mar 31, 2026 · filed May 12, 2026 · 42 d ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d ended Sep 30, 2026 · filed Nov 10, 2026 · 41 d window Mar 8 – Apr 2 · projected FY 2026 Q3 2026 Sep 30, 2026 — Nov 10, 2026 41 d 10-Q $91.00K −89.4% -$0.30 +5.6% Q2 2026 Jun 30, 2026 — Aug 10, 2026 41 d 10-Q $88.00K −89.5% -$0.38 1.8% Q1 2026 Mar 31, 2026 — May 12, 2026 42 d 10-Q $110.00K −87.3% -$0.33 0.2%
FY 2025 Q4 2025 derived Dec 31, 2025 — Mar 12, 2026 71 d 10-K $30.92M +12,120.2% — 4.8% Q3 2025 Sep 30, 2025 — Nov 10, 2025 41 d 10-Q $861.00K −12.8% -$0.40 +8.9% Q2 2025 Jun 30, 2025 — Aug 12, 2025 43 d 10-Q $836.00K +7.5% -$0.50 +7.9% Q1 2025 Mar 31, 2025 — May 12, 2025 42 d 10-Q $868.00K +40.0% -$0.49 +12.1%
FY 2024 Q4 2024 derived Dec 31, 2024 — Mar 31, 2025 90 d 10-K $253.00K −3.4% — 20.1% Q3 2024 Sep 30, 2024 — Nov 12, 2024 43 d 10-Q $987.00K +135.6% -$0.41 +6.3% Q2 2024 Jun 30, 2024 — Aug 12, 2024 43 d 10-Q $778.00K −15.0% -$0.45 — Q1 2024 Mar 31, 2024 — May 13, 2024 43 d 10-Q $620.00K −46.7% -$0.38 —
FY 2023 Q4 2023 derived Dec 31, 2023 — Mar 27, 2024 87 d 10-K $262.00K −76.2% — 0.8% Q3 2023 Sep 30, 2023 — Nov 13, 2023 44 d 10-Q $419.00K −64.0% -$0.38 +41.3% Q2 2023 Jun 30, 2023 — Aug 10, 2023 41 d 10-Q $915.00K +128.2% -$0.35 1.6% Q1 2023 Mar 31, 2023 — May 12, 2023 42 d 10-Q $1.16M +34.4% -$0.40 +2.5%
FY 2022 Q4 2022 derived Dec 31, 2022 — Jan 25, 2023 25 d 10-K $1.10M — — — Q3 2022 Sep 30, 2022 — Nov 14, 2022 45 d 10-Q $1.16M — -$0.51 — Q2 2022 Jun 30, 2022 — Aug 15, 2022 46 d 10-Q $401.00K — -$0.77 — Q1 2022 Mar 31, 2022 — May 13, 2022 43 d 10-Q $866.00K — -$0.62 —
FY 2021 Q4 2021 derived Dec 31, 2021 — Mar 31, 2022 90 d 10-K — — — — Q3 2021 Sep 30, 2021 — Nov 12, 2021 43 d 10-Q — — $0.00 — Q2 2021 Jun 30, 2021 — Aug 16, 2021 47 d 10-Q — — $0.00 — Q1 2021 Mar 31, 2021 — May 17, 2021 47 d 10-Q — — $0.00 —
FY 2020 Q3 2020 Sep 30, 2020 — Nov 5, 2020 36 d 10-Q — — $0.00 —
Earlier years, FY 2020 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 12, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue $30.92M Revenue, change from a year earlier: Q3 2026 −89.4%, Q2 2026 −89.5%, Q1 2026 −87.3%, Q4 2025 +12,120.2% +12,120.2% −87.3% −89.5% −89.4%
Net income $6.25M Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m n/m n/m n/m n/m
EPS — EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m n/m n/m n/m n/m +5.6% by the close of Nov 11
1.8% by the close of Aug 11
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: +41.3% after Q3 2023.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks